Impact of different model structure and prior distribution in continual reassessment method (Q5087922): Difference between revisions

@@ Property / cites work @@
+Optimal Bayesian-feasible dose escalation for cancer phase I trials
+Normal rank
@@ Property / cites work @@
+Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
+Normal rank
@@ Property / cites work @@
+A Curve‐Free Method for Phase I Clinical Trials
@@ Property / cites work: A Curve‐Free Method for Phase I Clinical Trials / rank @@
+Normal rank
@@ Property / cites work @@
+Bayesian model averaging: A tutorial. (with comments and a rejoinder).
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Group Sequential and Adaptive Designs – A Review of Basic Concepts and Points of Discussion
+Normal rank
@@ Property / cites work @@
+Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
+Normal rank